Bottom Fish Stocks (between .10 and$10)

[Katfish]

LICY - 1.10 Pre-market at 1.38/1.39

Li-Cycle Provides Business Update; Reports Significant Progress In Comprehensive Review, Incl. Improving Current Liquidity Position & Conducting Internal Technical Review Of Rochester Hub

[Katfish]

VERB - .36 Pre-market at .3875/.3902

VERB's MARKET.live Adds 100 More Retail Brands to its Livestream Social Shopping Platform

[Katfish]

ZCAR - 1.18 Pre-market at 1.81/1.82

Zoomcar Holdings Partners With India's EaseMyTrip

[Zardiw]

$PIXY Chart from #DDAmanda - #1 Stock Screener :

Scans are preset. Push a Button. Find Winners Early:



Z

[Katfish]

ZVSA - .8678 Up .0885 In pre-market on news out tis AM

ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator VAR 200 in Patients with Diabetic Kidney Disease

[Katfish]

LIDR - 1.15 Pre-market at 1.37/1.43

[Katfish]

TLRY - 1.73 Pre-market at 1.86/1.87

[Katfish]

GNS - .4199 Pre-market at .4568/.464

Genius Group Release Additional Details of FatBrain AI Transaction

[Katfish]

STI - 1.74 Now at 2.48/2.49

[Katfish]

VERB - .4422 Pre-market at .59/.591

[Katfish]

GLMD - .349 Pre-market at .4655/.4656

Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis

[Katfish]

STI - 1.30 Pre-market at 1.53/1.54

[Katfish]

MDAI - 2.42 Pre-market at 2.78/2.79

[Katfish]

VERB - .142 Pre-market at .485/.49

VERB's MARKET.live Launches Facebook and Instagram Social Shopping Technology Integration

[Katfish]

GERN - 1.75 Pre-market at 3.13/3.14

Cantor Fitzgerald Reiterates Overweight on BigBear.ai Hldgs, Maintains $3.5 Price Target

[Katfish]

JTAI - .6611 Pre-market at 1.12/1.13

[Zardiw]

$APM Chart from #DDAmanda - #1 Stock Screener :

Scans are preset. Push a Button. Find Winners Early:



Z

[Katfish]

APM - 4.33 Pre-market at 6.39/6.46

[Katfish]

BBAI - 2.46 Pre-market at 2.86/2.87

Cantor Fitzgerald Reiterates Overweight on BigBear.ai Hldgs, Maintains $3.5 Price Target

[Katfish]

NBY - .1416 Pre-market at .1684/.17

Novabay Pharmaceuticals Agrees To Sell Its DERMAdoctor Skincare Business Including All Product Inventory For Approximately $1M In Cash

[Katfish]

SOUN - 9.88/9.89 Still moving up.

[Katfish]

BBAI - 2.33 Pre-market at 2.46/2.47

Cantor Fitzgerald Reiterates Overweight on BigBear.ai Hldgs, Maintains $3.5 Price Target

[Katfish]

MINM - 5.01 Pre-market at 7.00/7.10

Minim shares are trading higher after the company announced that it entered into a definitive merger agreement with e2Companies.

[Katfish]

HOLO - 4.89 Pre-market at 5.75/5.78

[Katfish]

PIXY - 3.135 Pre-market at 4.43/4.44

[Katfish]

SOUN - 6.93 Pre-market at 7.22/7.23 .....it keeps moving higher.

[Katfish]

TNON - 1.45 Pre-market at 1.72/1.73

Tenon Medical shares are trading higher after the company reported better-than-expected Q4 GAAP EPS results.

[Katfish]

AGRX - 72895 Pre-market at 895/8975

Agile Therapeutics Announced That It Has Paid-off The Remainder Of Its Debt Facility With Perceptive Advisors. The Company Remains Focused On Growing Twirla And Advancing The Company's Business Plan

[Katfish]

NCNA - .38459 Pre-market at .8008/.805

NuCana shares are trading higher after the company was granted a US Patent for "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance."

[Katfish]

BGXX - .518 up .31

Bright Green Corp Signed An Agreement With Dalsem Greenhouse Technologies BV For $250M For Expansion Of Its Controlled Substances Drug Production Facility In Grants, New Mexico And Obtained $60M In Financing

[Katfish]

MDAI - 1.72 Pre-market at 2.02/2.03

Spectral AI Announces New U.S. Government Contract Valued At Over $500,000 To Further Accelerate The Development Of The Handheld Version Of DeepView Wound Imaging System

[Katfish]

IONM - .341 Pre-market at .47/.4736

Assure Holdings Selling IONM Business Assets to MPOWERHealth For Up to $4.5 Million

[Katfish]

CLRO - .9053 Pre-market at 1.57/1.58

*ClearOne: Board of Directors Declared a One-Time Special Cash Div of $0.50 Per Shr of ClearOne Common Stk, Payable on April 10 to Hldrs of Record on April 2 >CLRO

[Katfish]

LICY - .4011 Pre-market at .54/.543

Li-Cycle Announces $75 Million Strategic Investment from Glencore

[Katfish]

RGLS - 1.38 Pre-market at 2.18/2.19

Regulus Therapeutics Announces Positive Topline Data from the Second Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

[Katfish]

ATNF - 3.53 Pre-market at 4.10/4.21

[Katfish]

SONN - 1.85 Pre-market at 2.32/2.35

Sonnet BioTherapeutics Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study’s Initial Pre-Specified Objective

[Katfish]

LXRX - 2.17 Pre-market at 2.36/2.38

Lexicon shares are trading higher after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.

[Katfish]

MESO - 2.15 Pre-market at 2.62/2.63

Mesoblast Says FDA Supports Accelerated Approval Pathway for Heart Failure Treatment

[Katfish]

AUUD - 3.07 Pre-market at 4.01/4.04

[Katfish]

TCBP - 1.06 Pre-market at 2.05/2.06

https://stockcharts.com/sc3/ui/?s=TCBP

[Zardiw]

$AIMD Chart from #DDAmanda - #1 Stock Screener :

Scans are preset. Push a Button. Find Winners Early:



Z

[Katfish]

SOUN - 5.63 Pre-market at 6.06/6.07

[Katfish]

AIRE - 1.25 Pre-market at 1.52/1.53

[Katfish]

AIMD - 1.12 Pre-market at 2.50/2.51

[Katfish]

PBM - 1.27 Pre-market at 3.10/3.11

Psyence Biomedical’s Subsidiary, Psyence Australia, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study

[Katfish]

MNMD - 5.94 Pre-market at 7.30/7.31

MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder

[Katfish]

NKGN - 1.83 Pre-market at 2.25/2.27

[Katfish]

LYT 2.31 Pre-market at 7.22/7.28

Lytus Technologies shares are trading higher after the company announced the launch of Lytus Cloud.

[Katfish]

IMRN - 1.65 Pre-market at 3.35/3.40

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US